Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Probing the Role of Feature Dimension Maps in Visual Cognition: Impact of Task Demands and Spatial Attention (Expt 2.2)

1 de mayo de 2026 actualizado por: University of California, Santa Barbara

Probing the Role of Feature Dimension Maps in Visual Cognition: Expt 2.2

How does one know what to look at in a scene? Imagine a "Where's Waldo" game - it's challenging to find Waldo because there are many 'salient' locations in the picture, each vying for one's attention. One can only attend to a small location on the picture at a given moment, so to find Waldo, one needs to direct their attention to different locations. One prominent theory about how one accomplishes this claims that important locations are identified based on distinct feature types (for example, motion or color), with locations most unique compared to the background most likely to be attended. An important component of this theory is that individual feature dimensions (again, color or motion) are computed within their own 'feature maps', which are thought to be implemented in specific brain regions. However, whether and how specific brain regions contribute to these feature maps remains unknown.

The goal of this study is to determine how brain regions that respond strongly to different feature types (color and motion) and which encode spatial locations of visual stimuli transform 'feature dimension maps' based on stimulus properties as a function of task instructions. The investigators hypothesize that feature-selective brain regions act as neural feature dimension maps, and thus encode representations of relevant location(s) based on their preferred feature dimension, such that the stimulus representation in the most relevant feature map is up-regulated to support adaptive behavior. The investigators will scan healthy human participants using functional MRI (fMRI) in a repeated-measures design while they view visual stimuli made relevant based on a cued feature dimension (e.g., color or motion). The investigators will employ state-of-the-art multivariate analysis techniques that allow them to reconstruct an 'image' of the stimulus representation encoded by each brain region to dissect how neural tissue identifies salient locations. Each participant will perform a challenging discrimination task based on the cued feature (report motion direction or color of stimulus dots) of either a single stimulus presented in the periphery, which are identical across trial types, or multiple simultaneously-presented stimuli. Across trials the investigators will manipulate the attended feature value (color, motion, or fixation point) and number of attended stimuli (attend 1 stimulus, attend 2 stimuli). These manipulations will help the investigators fully understand these critical relevance computations in the healthy human visual system.

Descripción general del estudio

Descripción detallada

In this experiment, participants will engage in all task conditions in a repeated-measures design. Participants are not randomly assigned to groups, as all participants will experience the same set of experimental manipulations. In this experiment, participants will engage in a series of challenging visual attention tasks while their eye position is tracked during fMRI scanning.

In all tasks, participants will perform challenging discrimination judgments based on a stimulus presented at the fixation point (discriminate the aspect ratio of a + target - wide or tall?), or a stimulus/stimuli presented in the periphery (were the dots moving clockwise/counterclockwise? were the dots orange/cyan?). Behavioral responses will be recorded with a button press, which participants will make using a fMRI-compatible button box held in their right hand.

In this Experiment, the investigators will manipulate aspects of the behavioral task while keeping the stimulus display constant. These manipulations will allow the investigators to test the role of feature-selective retinotopic regions of interest (ROIs) in transforming spatial representations of salient locations as a function of task relevance to guide visual attention.

In this Experiment (Experiment 2.2), the investigators will present either a single stimulus or two stimuli at peripheral locations on a blank background containing equiluminant colored moving dots (orange and cyan dots, moving both clockwise and counterclockwise around the stimulus center). Participants will be cued at the beginning of each trial to report either the most prominent color of the dots (orange or cyan), the most prominent motion direction (clockwise or counterclockwise), or to perform a fixation task. Additionally, participants will be cued to attend to one stimulus or both stimuli. If attending to a feature dimension modulates the activation profiles within the corresponding dimension map, the investigators expect to see a selective enhancement of the stimulus representation in the dimension map of a region preferring the attended feature.

Participants will also be scanned for an anatomical & retinotopic mapping session, which will allow the investigators to identify brain regions for further analysis using well-established and standardized procedures.

STATISTICAL DESIGN & POWER The fMRI studies described in this study record employ an inverted encoding model (IEM) for spatial position to quantify stimulus representations in reconstructed spatial maps of the visual field based on activation patterns measured in retinotopic feature-selective ROIs. The investigators rigorously identify ROIs using independent retinotopic mapping and localizer techniques, and use a 'mapping' task to estimate a 'fixed' encoding model for use across all conditions in each Experiment reported. These design decisions ensure that the investigators can maximize their ability to detect effects of their manipulations of interest within individual participants and brain regions and maximize the statistical power. The investigators use a compromise between deep imaging of several experimental and stimulus conditions within individual participants and aggregation of data across a moderate sample of these deeply-imaged participants (n = 12). This allows the investigators to attain high-quality, reproducible estimates of model-based stimulus representations across task and stimulus manipulations within individual participants and conduct statistical inference on these measurements across the study sample.

fMRI analyses will be conducted within each participant's individual brain, and voxels are assigned 'region' labels according to independent criteria (functional retinotopic mapping). Accordingly, there are no comparisons that require precise alignment of brain tissue between participants, and no generation of group-averaged 'maps' of brain activation. As such, concerns about reproducibility of brain maps and associated statistical power concerns are irrelevant to this study design.

The statistical design of the study is a repeated-measures design, whereby each participant is exposed to all manipulations in the study. The order of manipulations each participant experiences is randomized across participants. The investigators will employ nonparametric randomization tests for all statistical comparisons whereby they will conduct hypothesis testing (e.g., repeated-measures analysis of variance) using 'shuffled' data (misaligned condition labels relative to measured map activation on each trial) to generate a null distribution of test statistics under the null hypothesis of no effect of their independent variable(s). Once this procedure is repeated extensively (1,000 times) per test, the p-value can be estimated by comparing the test statistic computed using intact labels to this null distribution, and corrected for multiple comparisons as appropriate (e.g., via false discovery rate). Using permutation procedures to generate a null distribution minimizes reliance on parametric assumptions.

Additionally, the experiments within the study are designed such that sufficient data will be acquired that data from each individual participant can be used to test the effects of interest. Accordingly, each participant can be considered independent 'replication' of each other participant. Previous studies adopting a similar methodology whereby IEM-based reconstructions of visual stimuli are compared between conditions have employed relatively small sample sizes (n = 7-8). Other studies using population receptive field models or location-specific functional localizer, which are in principle very similar to the approach employed here, have used smaller sample sizes (e.g., n = 6).

Sample size & statistical power:

In this study, the investigators will acquire an intermediate sample size with extensive data per task condition (n = 12; 2 experimental fMRI sessions, each 1.5-2 hrs, for each participant; along with a 2-hr anatomical imaging and retinotopic mapping fMRI session). Of particular interest, one study used n = 6 participants to establish with a large effect size dz = 3.52 that V1 voxels tuned to a stimulus location where a salient stimulus was defined by feature contrast respond more strongly than when feature contrast is absent. In another study, similar effect sizes were reported by this group in a color-selective ROI known as hV4 (n = 6; dz = 1.06 and 1.80 for orientation- and motion-based contrast, respectively).

Accordingly, assuming a conservative effect size of 0.90 (based on those reported previously), the investigators expect a sample size of n = 10 will allow the study to be well-powered (80%, α = 0.05) to detect a similar change in Experiment 1.1, which is most analogous to this study (one-tailed paired T-test).

Additionally, the investigators used their pilot data (n = 3) to measure the effect size for the critical comparison between salience-related modulations between feature-selective regions to be dz = 3.10 for the salience-defining feature. These values are commensurate with those cited above, and further support the selection of sample size. If analyses of data acquired during further pilot testing & experiment refinement suggest smaller effect sizes, the investigators will refine the power analyses and adjust the projected enrollment accordingly to ensure robust and reproducible results. Note that this power analysis relies on parametric assumptions which will not be required for the proposed analyses, which invoke randomization methods to compute empirical null distributions.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

12

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • California
      • Santa Barbara, California, Estados Unidos, 93117
        • University of California, Santa Barbara

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto

Acepta Voluntarios Saludables

Sí

Descripción

Inclusion Criteria:

  • between 18 and 55 years of age
  • normal or corrected-to-normal vision

Exclusion Criteria:

  • neurological disease based on self-report
  • implanted medical devices (e.g., cardiac pacemaker; metallic aneurism clip)
  • non-removable metallic piercings
  • metal fragments in the body (e.g., from welding)
  • pregnant and have a chance of being pregnant (if female)
  • history of claustrophobia
  • history of hearing loss/damage

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Ciencia básica
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Manipulations of task demands and attended location(s) (Expt 2.2)
Participants will view one or two peripheral stimuli containing dots moving in one of two directions (clock-wise or counterclockwise) and drawn in one of two colors (orange and cyan). A cue at fixation will indicate the relevant feature and stimulus/stimuli for task completion
La característica utilizada para determinar a qué característica del estímulo prestar atención variará en las pruebas utilizando una señal de letra (M = atención al movimiento, C = atención al color, F = atención a la fijación)

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Strength of stimulus representation quantified by map activation at stimulus location(s) derived from multivariate analysis of functional MRI data
Periodo de tiempo: During each fMRI scanning session throughout enrollment (sessions will be scheduled to occur within 1-2 weeks of enrollment).
Measurement of fMRI BOLD activation at stimulus location in reconstructed neural priority maps computed using spatial IEM in each retinotopic ROI (motion- and color-selective)
During each fMRI scanning session throughout enrollment (sessions will be scheduled to occur within 1-2 weeks of enrollment).
Discrimination accuracy derived from behavioral performance during fMRI scanning, acquired using fMRI button box
Periodo de tiempo: During each fMRI scanning session throughout enrollment (sessions will be scheduled to occur within 1-2 weeks of enrollment).
Performance (% correct responses) at challenging discrimination tasks performed at fixation or stimulus location(s)
During each fMRI scanning session throughout enrollment (sessions will be scheduled to occur within 1-2 weeks of enrollment).
Response time derived from behavioral performance during fMRI scanning, acquired using fMRI button box
Periodo de tiempo: During each fMRI scanning session throughout enrollment (sessions will be scheduled to occur within 1-2 weeks of enrollment).
Performance (time until response registered) when making challenging discrimination tasks
During each fMRI scanning session throughout enrollment (sessions will be scheduled to occur within 1-2 weeks of enrollment).
Discrimination thresholds derived from behavioral performance during fMRI scanning, acquired using fMRI button box
Periodo de tiempo: During each fMRI scanning session throughout enrollment (sessions will be scheduled to occur within 1-2 weeks of enrollment).
Level of stimulus change necessary to equate behavioral performance across conditions, which is a measure of strength of information available to participants about attended feature/stimuli
During each fMRI scanning session throughout enrollment (sessions will be scheduled to occur within 1-2 weeks of enrollment).

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Tommy C Sprague, University of California, Santa Barbara

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

22 de enero de 2026

Finalización primaria (Estimado)

15 de septiembre de 2026

Finalización del estudio (Estimado)

15 de septiembre de 2026

Fechas de registro del estudio

Enviado por primera vez

17 de abril de 2026

Primero enviado que cumplió con los criterios de control de calidad

1 de mayo de 2026

Publicado por primera vez (Actual)

7 de mayo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

7 de mayo de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

1 de mayo de 2026

Última verificación

1 de mayo de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 5-24-0030: 2.2
  • R01EY035300 (Subvención/contrato del NIH de EE. UU.)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

Processed fMRI and raw behavioral data will be shared with researchers immediately upon publication

Marco de tiempo para compartir IPD

Data will be available indefinitely beginning with publication of results

Criterios de acceso compartido de IPD

Processed fMRI data and raw behavioral/eyetracking data will be publicly available on the lab's Open Science Framework page (https://osf.io/ufjzl/), and analysis code will be available on GitHub (an online tool for storing and managing code; github.com/SpragueLab). Raw, unprocessed fMRI data will be made available upon justifiable request from qualified researchers

Tipo de información de apoyo para compartir IPD

  • PROTOCOLO DE ESTUDIO
  • SAVIA
  • CIF
  • CÓDIGO_ANALÍTICO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir